ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Methotrexate API Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-2T17605
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Methotrexate API Market Research Report 2024
BUY CHAPTERS

Global Methotrexate API Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-2T17605
Report
October 2025
Pages:164
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Rochem International
Fermion
Avra Laboratories
LGM Pharma
CF Pharma
HRV Global
SIGMAK LIFESCIENCES
Aspen Biopharma
BioVectra
Bulat Pharmaceutical
South Pharmaceutical
Elixir Pharmaceuticals
Mesochem Technology
Think Chemical

Methotrexate API Market

The global Methotrexate API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Acute Lymphoblastic Leukemia accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Methotrexate API leading manufacturers including Rochem International, Fermion, Avra Laboratories, LGM Pharma, CF Pharma, HRV Global, Elixir Pharmaceuticals, Sigmak Lifesciences, Aspen Biopharma, Mesochem Technology, etc., dominate supply; the top five capture approximately % of global revenue, with Rochem International leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Methotrexate API market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Purity and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Methotrexate API Market Report

Report Metric Details
Report Name Methotrexate API Market
Segment by Purity
  • Below 98%
  • Above 98%
Segment by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Rochem International, Fermion, Avra Laboratories, LGM Pharma, CF Pharma, HRV Global, Elixir Pharmaceuticals, Sigmak Lifesciences, Aspen Biopharma, Mesochem Technology, BioVectra, Bulat Pharmaceutical, South Pharmaceutical, Think Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Methotrexate API study scope, segments the market by Purity and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Purity, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Purity, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Purity, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Purity, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Purity, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Methotrexate API Market report?

Ans: The main players in the Methotrexate API Market are Rochem International, Fermion, Avra Laboratories, LGM Pharma, CF Pharma, HRV Global, Elixir Pharmaceuticals, Sigmak Lifesciences, Aspen Biopharma, Mesochem Technology, BioVectra, Bulat Pharmaceutical, South Pharmaceutical, Think Chemical

What are the Application segmentation covered in the Methotrexate API Market report?

Ans: The Applications covered in the Methotrexate API Market report are Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Psoriasis, Rheumatoid Arthritis, Others

Recommended Reports

Active Pharmaceutical Ingredients

Oncology APIs & Drugs

Antibiotic & Anti-Inflammatory APIs

1 Study Coverage
1.1 Introduction to Methotrexate API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Purity
1.2.1 Global Methotrexate API Market Size by Purity, 2020 VS 2024 VS 2031
1.2.2 Below 98%
1.2.3 Above 98%
1.3 Market Segmentation by Application
1.3.1 Global Methotrexate API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Acute Lymphoblastic Leukemia
1.3.3 Non-Hodgkin's Lymphoma
1.3.4 Psoriasis
1.3.5 Rheumatoid Arthritis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Methotrexate API Revenue Estimates and Forecasts 2020-2031
2.2 Global Methotrexate API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Methotrexate API Sales Estimates and Forecasts 2020-2031
2.4 Global Methotrexate API Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Methotrexate API Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Methotrexate API Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Methotrexate API Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Below 98% Market Size by Manufacturers
4.5.2 Above 98% Market Size by Manufacturers
4.6 Global Methotrexate API Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Methotrexate API Sales Performance by Purity
5.1.1 Global Historical and Forecasted Sales by Purity (2020-2031)
5.1.2 Global Sales Market Share by Purity (2020-2031)
5.2 Global Methotrexate API Revenue Trends by Purity
5.2.1 Global Historical and Forecasted Revenue by Purity (2020-2031)
5.2.2 Global Revenue Market Share by Purity (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Purity (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Methotrexate API Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Methotrexate API Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Methotrexate API Sales and Revenue by Purity (2020-2031)
7.4 North America Methotrexate API Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Methotrexate API Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Methotrexate API Sales and Revenue by Purity (2020-2031)
8.4 Europe Methotrexate API Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Methotrexate API Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Methotrexate API Sales and Revenue by Purity (2020-2031)
9.4 Asia-Pacific Methotrexate API Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Methotrexate API Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Methotrexate API Sales and Revenue by Purity (2020-2031)
10.4 Central and South America Methotrexate API Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Methotrexate API Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Methotrexate API Sales and Revenue by Purity (2020-2031)
11.4 Middle East and Africa Methotrexate API Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Methotrexate API Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Rochem International
12.1.1 Rochem International Corporation Information
12.1.2 Rochem International Business Overview
12.1.3 Rochem International Methotrexate API Product Models, Descriptions and Specifications
12.1.4 Rochem International Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Rochem International Methotrexate API Sales by Product in 2024
12.1.6 Rochem International Methotrexate API Sales by Application in 2024
12.1.7 Rochem International Methotrexate API Sales by Geographic Area in 2024
12.1.8 Rochem International Methotrexate API SWOT Analysis
12.1.9 Rochem International Recent Developments
12.2 Fermion
12.2.1 Fermion Corporation Information
12.2.2 Fermion Business Overview
12.2.3 Fermion Methotrexate API Product Models, Descriptions and Specifications
12.2.4 Fermion Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Fermion Methotrexate API Sales by Product in 2024
12.2.6 Fermion Methotrexate API Sales by Application in 2024
12.2.7 Fermion Methotrexate API Sales by Geographic Area in 2024
12.2.8 Fermion Methotrexate API SWOT Analysis
12.2.9 Fermion Recent Developments
12.3 Avra Laboratories
12.3.1 Avra Laboratories Corporation Information
12.3.2 Avra Laboratories Business Overview
12.3.3 Avra Laboratories Methotrexate API Product Models, Descriptions and Specifications
12.3.4 Avra Laboratories Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Avra Laboratories Methotrexate API Sales by Product in 2024
12.3.6 Avra Laboratories Methotrexate API Sales by Application in 2024
12.3.7 Avra Laboratories Methotrexate API Sales by Geographic Area in 2024
12.3.8 Avra Laboratories Methotrexate API SWOT Analysis
12.3.9 Avra Laboratories Recent Developments
12.4 LGM Pharma
12.4.1 LGM Pharma Corporation Information
12.4.2 LGM Pharma Business Overview
12.4.3 LGM Pharma Methotrexate API Product Models, Descriptions and Specifications
12.4.4 LGM Pharma Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 LGM Pharma Methotrexate API Sales by Product in 2024
12.4.6 LGM Pharma Methotrexate API Sales by Application in 2024
12.4.7 LGM Pharma Methotrexate API Sales by Geographic Area in 2024
12.4.8 LGM Pharma Methotrexate API SWOT Analysis
12.4.9 LGM Pharma Recent Developments
12.5 CF Pharma
12.5.1 CF Pharma Corporation Information
12.5.2 CF Pharma Business Overview
12.5.3 CF Pharma Methotrexate API Product Models, Descriptions and Specifications
12.5.4 CF Pharma Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 CF Pharma Methotrexate API Sales by Product in 2024
12.5.6 CF Pharma Methotrexate API Sales by Application in 2024
12.5.7 CF Pharma Methotrexate API Sales by Geographic Area in 2024
12.5.8 CF Pharma Methotrexate API SWOT Analysis
12.5.9 CF Pharma Recent Developments
12.6 HRV Global
12.6.1 HRV Global Corporation Information
12.6.2 HRV Global Business Overview
12.6.3 HRV Global Methotrexate API Product Models, Descriptions and Specifications
12.6.4 HRV Global Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 HRV Global Recent Developments
12.7 Elixir Pharmaceuticals
12.7.1 Elixir Pharmaceuticals Corporation Information
12.7.2 Elixir Pharmaceuticals Business Overview
12.7.3 Elixir Pharmaceuticals Methotrexate API Product Models, Descriptions and Specifications
12.7.4 Elixir Pharmaceuticals Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Elixir Pharmaceuticals Recent Developments
12.8 Sigmak Lifesciences
12.8.1 Sigmak Lifesciences Corporation Information
12.8.2 Sigmak Lifesciences Business Overview
12.8.3 Sigmak Lifesciences Methotrexate API Product Models, Descriptions and Specifications
12.8.4 Sigmak Lifesciences Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Sigmak Lifesciences Recent Developments
12.9 Aspen Biopharma
12.9.1 Aspen Biopharma Corporation Information
12.9.2 Aspen Biopharma Business Overview
12.9.3 Aspen Biopharma Methotrexate API Product Models, Descriptions and Specifications
12.9.4 Aspen Biopharma Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Aspen Biopharma Recent Developments
12.10 Mesochem Technology
12.10.1 Mesochem Technology Corporation Information
12.10.2 Mesochem Technology Business Overview
12.10.3 Mesochem Technology Methotrexate API Product Models, Descriptions and Specifications
12.10.4 Mesochem Technology Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Mesochem Technology Recent Developments
12.11 BioVectra
12.11.1 BioVectra Corporation Information
12.11.2 BioVectra Business Overview
12.11.3 BioVectra Methotrexate API Product Models, Descriptions and Specifications
12.11.4 BioVectra Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 BioVectra Recent Developments
12.12 Bulat Pharmaceutical
12.12.1 Bulat Pharmaceutical Corporation Information
12.12.2 Bulat Pharmaceutical Business Overview
12.12.3 Bulat Pharmaceutical Methotrexate API Product Models, Descriptions and Specifications
12.12.4 Bulat Pharmaceutical Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Bulat Pharmaceutical Recent Developments
12.13 South Pharmaceutical
12.13.1 South Pharmaceutical Corporation Information
12.13.2 South Pharmaceutical Business Overview
12.13.3 South Pharmaceutical Methotrexate API Product Models, Descriptions and Specifications
12.13.4 South Pharmaceutical Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 South Pharmaceutical Recent Developments
12.14 Think Chemical
12.14.1 Think Chemical Corporation Information
12.14.2 Think Chemical Business Overview
12.14.3 Think Chemical Methotrexate API Product Models, Descriptions and Specifications
12.14.4 Think Chemical Methotrexate API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Think Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Methotrexate API Industry Chain
13.2 Methotrexate API Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Methotrexate API Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Methotrexate API Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Methotrexate API Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Methotrexate API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
FEATURED COMPANIES
Rochem International
Fermion
Avra Laboratories
LGM Pharma
CF Pharma
HRV Global
SIGMAK LIFESCIENCES
Aspen Biopharma
BioVectra
Bulat Pharmaceutical
South Pharmaceutical
Elixir Pharmaceuticals
Mesochem Technology
Think Chemical
List of Tables
 Table 1. Global Methotrexate API Market Size Growth Rate by Purity, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Methotrexate API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Methotrexate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Methotrexate API Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Methotrexate API Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Methotrexate API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Methotrexate API Sales by Region (2020-2025) & (Tons)
 Table 8. Global Methotrexate API Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Methotrexate API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Methotrexate API Production by Region (2020-2025) & (Tons)
 Table 12. Global Methotrexate API Production by Region (2026-2031) & (Tons)
 Table 13. Global Methotrexate API Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Methotrexate API Sales Share by Manufacturers (2020-2025)
 Table 15. Global Methotrexate API Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Methotrexate API Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Methotrexate API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methotrexate API as of 2024)
 Table 19. Global Methotrexate API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Methotrexate API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Methotrexate API Manufacturing Base and Headquarters
 Table 22. Global Methotrexate API Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Methotrexate API Sales by Purity (2020-2025) & (Tons)
 Table 26. Global Methotrexate API Sales by Purity (2026-2031) & (Tons)
 Table 27. Global Methotrexate API Revenue by Purity (2020-2025) & (US$ Million)
 Table 28. Global Methotrexate API Revenue by Purity (2026-2031) & (US$ Million)
 Table 29. Global Methotrexate API ASP by Purity (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Methotrexate API Sales by Application (2020-2025) & (Tons)
 Table 32. Global Methotrexate API Sales by Application (2026-2031) & (Tons)
 Table 33. Methotrexate API High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Methotrexate API Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Methotrexate API Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Methotrexate API ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Methotrexate API Growth Accelerators and Market Barriers
 Table 40. North America Methotrexate API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Methotrexate API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Methotrexate API Growth Accelerators and Market Barriers
 Table 43. Europe Methotrexate API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Methotrexate API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Methotrexate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Methotrexate API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Methotrexate API Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Methotrexate API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Methotrexate API Investment Opportunities and Key Challenges
 Table 50. Central and South America Methotrexate API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Methotrexate API Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Methotrexate API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Rochem International Corporation Information
 Table 54. Rochem International Description and Major Businesses
 Table 55. Rochem International Product Models, Descriptions and Specifications
 Table 56. Rochem International Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Rochem International Sales Value Proportion by Product in 2024
 Table 58. Rochem International Sales Value Proportion by Application in 2024
 Table 59. Rochem International Sales Value Proportion by Geographic Area in 2024
 Table 60. Rochem International Methotrexate API SWOT Analysis
 Table 61. Rochem International Recent Developments
 Table 62. Fermion Corporation Information
 Table 63. Fermion Description and Major Businesses
 Table 64. Fermion Product Models, Descriptions and Specifications
 Table 65. Fermion Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Fermion Sales Value Proportion by Product in 2024
 Table 67. Fermion Sales Value Proportion by Application in 2024
 Table 68. Fermion Sales Value Proportion by Geographic Area in 2024
 Table 69. Fermion Methotrexate API SWOT Analysis
 Table 70. Fermion Recent Developments
 Table 71. Avra Laboratories Corporation Information
 Table 72. Avra Laboratories Description and Major Businesses
 Table 73. Avra Laboratories Product Models, Descriptions and Specifications
 Table 74. Avra Laboratories Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Avra Laboratories Sales Value Proportion by Product in 2024
 Table 76. Avra Laboratories Sales Value Proportion by Application in 2024
 Table 77. Avra Laboratories Sales Value Proportion by Geographic Area in 2024
 Table 78. Avra Laboratories Methotrexate API SWOT Analysis
 Table 79. Avra Laboratories Recent Developments
 Table 80. LGM Pharma Corporation Information
 Table 81. LGM Pharma Description and Major Businesses
 Table 82. LGM Pharma Product Models, Descriptions and Specifications
 Table 83. LGM Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. LGM Pharma Sales Value Proportion by Product in 2024
 Table 85. LGM Pharma Sales Value Proportion by Application in 2024
 Table 86. LGM Pharma Sales Value Proportion by Geographic Area in 2024
 Table 87. LGM Pharma Methotrexate API SWOT Analysis
 Table 88. LGM Pharma Recent Developments
 Table 89. CF Pharma Corporation Information
 Table 90. CF Pharma Description and Major Businesses
 Table 91. CF Pharma Product Models, Descriptions and Specifications
 Table 92. CF Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. CF Pharma Sales Value Proportion by Product in 2024
 Table 94. CF Pharma Sales Value Proportion by Application in 2024
 Table 95. CF Pharma Sales Value Proportion by Geographic Area in 2024
 Table 96. CF Pharma Methotrexate API SWOT Analysis
 Table 97. CF Pharma Recent Developments
 Table 98. HRV Global Corporation Information
 Table 99. HRV Global Description and Major Businesses
 Table 100. HRV Global Product Models, Descriptions and Specifications
 Table 101. HRV Global Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. HRV Global Recent Developments
 Table 103. Elixir Pharmaceuticals Corporation Information
 Table 104. Elixir Pharmaceuticals Description and Major Businesses
 Table 105. Elixir Pharmaceuticals Product Models, Descriptions and Specifications
 Table 106. Elixir Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Elixir Pharmaceuticals Recent Developments
 Table 108. Sigmak Lifesciences Corporation Information
 Table 109. Sigmak Lifesciences Description and Major Businesses
 Table 110. Sigmak Lifesciences Product Models, Descriptions and Specifications
 Table 111. Sigmak Lifesciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Sigmak Lifesciences Recent Developments
 Table 113. Aspen Biopharma Corporation Information
 Table 114. Aspen Biopharma Description and Major Businesses
 Table 115. Aspen Biopharma Product Models, Descriptions and Specifications
 Table 116. Aspen Biopharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Aspen Biopharma Recent Developments
 Table 118. Mesochem Technology Corporation Information
 Table 119. Mesochem Technology Description and Major Businesses
 Table 120. Mesochem Technology Product Models, Descriptions and Specifications
 Table 121. Mesochem Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. Mesochem Technology Recent Developments
 Table 123. BioVectra Corporation Information
 Table 124. BioVectra Description and Major Businesses
 Table 125. BioVectra Product Models, Descriptions and Specifications
 Table 126. BioVectra Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. BioVectra Recent Developments
 Table 128. Bulat Pharmaceutical Corporation Information
 Table 129. Bulat Pharmaceutical Description and Major Businesses
 Table 130. Bulat Pharmaceutical Product Models, Descriptions and Specifications
 Table 131. Bulat Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 132. Bulat Pharmaceutical Recent Developments
 Table 133. South Pharmaceutical Corporation Information
 Table 134. South Pharmaceutical Description and Major Businesses
 Table 135. South Pharmaceutical Product Models, Descriptions and Specifications
 Table 136. South Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 137. South Pharmaceutical Recent Developments
 Table 138. Think Chemical Corporation Information
 Table 139. Think Chemical Description and Major Businesses
 Table 140. Think Chemical Product Models, Descriptions and Specifications
 Table 141. Think Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 142. Think Chemical Recent Developments
 Table 143. Key Raw Materials Distribution
 Table 144. Raw Materials Key Suppliers
 Table 145. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 146. Milestones in Production Technology Evolution
 Table 147. Distributors List
 Table 148. Market Trends and Market Evolution
 Table 149. Market Drivers and Opportunities
 Table 150. Market Challenges, Risks, and Restraints
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources


List of Figures
 Figure 1. Methotrexate API Product Picture
 Figure 2. Global Methotrexate API Market Size Growth Rate by Purity, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Below 98% Product Picture
 Figure 4. Above 98% Product Picture
 Figure 5. Global Methotrexate API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Acute Lymphoblastic Leukemia
 Figure 7. Non-Hodgkin's Lymphoma
 Figure 8. Psoriasis
 Figure 9. Rheumatoid Arthritis
 Figure 10. Others
 Figure 11. Methotrexate API Report Years Considered
 Figure 12. Global Methotrexate API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Methotrexate API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Methotrexate API Revenue Market Share by Region (2020-2031)
 Figure 16. Global Methotrexate API Sales (2020-2031) & (Tons)
 Figure 17. Global Methotrexate API Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 18. Global Methotrexate API Sales Market Share by Region (2020-2031)
 Figure 19. Global Methotrexate API Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 20. Global Methotrexate API Production Trend by Region (2020-2031) (Tons)
 Figure 21. Global Methotrexate API Production Market Share by Region (2020-2031)
 Figure 22. Production Capacity Enablers & Constraints
 Figure 23. Methotrexate API Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 24. Methotrexate API Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 25. Methotrexate API Production Growth Rate in China (2020-2031) & (Tons)
 Figure 26. Methotrexate API Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 27. Top 5 and Top 10 Manufacturers Methotrexate API Sales Volume Market Share in 2024
 Figure 28. Global Methotrexate API Revenue Market Share Ranking (2024)
 Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 30. Below 98% Revenue Market Share by Manufacturer in 2024
 Figure 31. Above 98% Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 34. Global Methotrexate API Sales Market Share by Purity (2020-2031)
 Figure 35. Global Methotrexate API Revenue Market Share by Purity (2020-2031)
 Figure 36. Global Methotrexate API Sales Market Share by Application (2020-2031)
 Figure 37. Global Methotrexate API Revenue Market Share by Application (2020-2031)
 Figure 38. North America Methotrexate API Sales YoY (2020-2031) & (Tons)
 Figure 39. North America Methotrexate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. North America Top 5 Manufacturers Methotrexate API Sales Revenue (US$ Million) in 2024
 Figure 41. North America Methotrexate API Sales Volume (Tons) by Purity (2020- 2031)
 Figure 42. North America Methotrexate API Sales Revenue (US$ Million) by Purity (2020 - 2031)
 Figure 43. North America Methotrexate API Sales Volume (Tons) by Application (2020-2031)
 Figure 44. North America Methotrexate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. US Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 46. Canada Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 47. Mexico Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 48. Europe Methotrexate API Sales YoY (2020-2031) & (Tons)
 Figure 49. Europe Methotrexate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Europe Top 5 Manufacturers Methotrexate API Sales Revenue (US$ Million) in 2024
 Figure 51. Europe Methotrexate API Sales Volume (Tons) by Purity (2020-2031)
 Figure 52. Europe Methotrexate API Sales Revenue (US$ Million) by Purity (2020-2031)
 Figure 53. Europe Methotrexate API Sales Volume (Tons) by Application (2020-2031)
 Figure 54. Europe Methotrexate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Germany Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 56. France Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 57. U.K. Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 58. Italy Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 59. Russia Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Methotrexate API Sales YoY (2020-2031) & (Tons)
 Figure 61. Asia-Pacific Methotrexate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific Top 8 Manufacturers Methotrexate API Sales Revenue (US$ Million) in 2024
 Figure 63. Asia-Pacific Methotrexate API Sales Volume (Tons) by Purity (2020- 2031)
 Figure 64. Asia-Pacific Methotrexate API Sales Revenue (US$ Million) by Purity (2020- 2031)
 Figure 65. Asia-Pacific Methotrexate API Sales Volume (Tons) by Application (2020-2031)
 Figure 66. Asia-Pacific Methotrexate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Indonesia Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 68. Japan Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 69. South Korea Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 70. China Taiwan Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 71. India Methotrexate API Revenue (2020-2031) & (US$ Million)
 Figure 72. Central and South America Methotrexate API Sales YoY (2020-2031) & (Tons)
 Figure 73. Central and South America Methotrexate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Central and South America Top 5 Manufacturers Methotrexate API Sales Revenue (US$ Million) in 2024
 Figure 75. Central and South America Methotrexate API Sales Volume (Tons) by Purity (2021-2031)
 Figure 76. Central and South America Methotrexate API Sales Revenue (US$ Million) by Purity (2020-2031)
 Figure 77. Central and South America Methotrexate API Sales Volume (Tons) by Application (2020-2031)
 Figure 78. Central and South America Methotrexate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. Brazil Methotrexate API Revenue (2020-2025) & (US$ Million)
 Figure 80. Argentina Methotrexate API Revenue (2020-2025) & (US$ Million)
 Figure 81. Middle East, and Africa Methotrexate API Sales YoY (2020-2031) & (Tons)
 Figure 82. Middle East and Africa Methotrexate API Revenue YoY (2020-2031) & (US$ Million)
 Figure 83. Middle East and Africa Top 5 Manufacturers Methotrexate API Sales Revenue (US$ Million) in 2024
 Figure 84. Middle East and Africa Methotrexate API Sales Volume (Tons) by Purity (2021-2031)
 Figure 85. South America Methotrexate API Sales Revenue (US$ Million) by Purity (2020-2031)
 Figure 86. Middle East and Africa Methotrexate API Sales Volume (Tons) by Application (2020-2031)
 Figure 87. Middle East and Africa Methotrexate API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 88. GCC Countries Methotrexate API Revenue (2020-2025) & (US$ Million)
 Figure 89. Turkey Methotrexate API Revenue (2020-2025) & (US$ Million)
 Figure 90. Egypt Methotrexate API Revenue (2020-2025) & (US$ Million)
 Figure 91. South Africa Methotrexate API Revenue (2020-2025) & (US$ Million)
 Figure 92. Methotrexate API Industry Chain Mapping
 Figure 93. Regional Methotrexate API Manufacturing Base Distribution (%)
 Figure 94. Methotrexate API Production Process
 Figure 95. Regional Methotrexate API Production Cost Structure
 Figure 96. Channels of Distribution (Direct Vs Distribution)
 Figure 97. Bottom-up and Top-down Approaches for This Report
 Figure 98. Data Triangulation
 Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Methotrexate Tablets Market Research Report 2025
Global Lemborexant API Market Research Report 2024
Global Azathioprine API Market Research Report 2025
Global Docetaxel API Market Research Report 2025
Global Metilprednisolone API Market Research Report 2024
Global Metaxalone API Market Research Report 2024
Methotrexate Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Methimazole API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Flavoxate API Market Research Report 2024
Global Thiothixene API Market Research Report 2025
Global Adenosine API Market Research Report 2025
Global Prednisolone API Market Research Report 2025
Global Mercaptopurine API Market Research Report 2025
Metformin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Calcitriol API Market Research Report 2024
Diethyl Methyl Malonate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Azithromycin API Market Research Report 2024
Cimetidine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cytarabine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Larotrectinib API Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions